Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share

August 9, 2016 9:20 AM EDT
Get Alerts RPRX Hot Sheet
Trade RPRX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.

For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment